选择语言

Human LILRB2 / CD85d / ILT4 Protein, His Tag (MALS verified)

用户评价
货号-规格
价格
Qty.

LI2-H5220-100ug
¥2730.00

LI2-H5220-1mg (250ug X 4)
¥16800.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    LILRB2,ILT4,LIR2,MIR10,CD85d

  • 表达区间及表达系统(Source)

    Human LILRB2, His Tag (LI2-H5220) is expressed from human 293 cells (HEK293). It contains AA Gln 22 - Val 461 (Accession # AAH36827).

    Predicted N-terminus: Gln 22

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    LILRB2 Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 48.6 kDa. The protein migrates as 58-67 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • 纯度(Purity)

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 电泳(SDS-PAGE)

    LILRB2 SDS-PAGE

    Human LILRB2, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    LILRB2 SEC-MALS

    The purity of Human LILRB2, His Tag (Cat. No. LI2-H5220) is more than 90% and the molecular weight of this protein is around 58-78 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     LILRB2 ELISA

    Immobilized Human LILRB2, His Tag (Cat. No. LI2-H5220) at 1 μg/mL (100 μL/well) can bind Anti-LILRB2 Antibody, Human IgG1 with a linear range of 0.5-4 ng/mL (QC tested).

    Protocol

用户评价
发表评论

背景介绍

Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

前沿进展

 
药物研发进展
  • 英文全称:

    Leukocyte immunoglobulin-like receptor subfamily B member 2

  • 中文全称:

    白细胞免疫球蛋白样受体亚家族B成员2

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    12 详情

  • 最高研发阶段:

    临床二期

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价
  • 背景介绍